Conditions and Procedures

IMAGE HERE

UW’s urologic oncology team offers several early-detection procedures for people at high risk of bladder cancer and innovative treatment options for early-stage and advanced bladder cancer.

UW surgeons were early to adopt the novel blue light cystoscopy technology using Cysview, a fluorescent marker that binds to cancerous cells in the bladder, allowing for detection of cancers that traditional white light cystoscopy would miss.

UW is considered a high-volume surgical center for both robotic and open radical cystectomy, the gold standard in the treatment of muscle invasive bladder cancer. Our clinicians employ a multidisciplinary approach to determining which patients will benefit from chemotherapy prior to surgery and are actively working toward advancing imaging technologies such as magnetic resonance imaging (MRI) to improve bladder cancer staging. Our surgeons are national leaders and chairpersons of the national cancer survivorship programs sponsored by the Bladder Cancer Advocacy Network (BCAN).

More information at UW Health

As kidney cancer cases in the United States continue to rise each year, the Urologic Oncology team at UW remains committed to providing the most comprehensive cancer treatment to each of our kidney cancer patients.

The kidney cancer team considers all options with each patient and forms a treatment plan according to an individual patient’s decisions. Our urologic oncology surgeons employ minimally invasive techniques using the latest technology to provide curative options that will have the least impact on patient lives. Individuals with locally-advanced or metastatic kidney cancer see surgeons, medical oncologists, and radiation specialists who provide treatment options only available at national centers of excellence.

Further, nutritional therapy and alternative therapy approaches are available to improve patient quality of life throughout and after treatment.

More information at UW Health